|
Symbol
|
RMA3QV | LZQRCH | QXPRCH | RMAKZV | AEFRTQ | RMA0TV | ADIESQ | RMBXZV | ROMRCH | AFNHTQ | RMB4JV | RMADEV | AFWPTQ | RMB5TV | MBWRCH | RMBTQV | RMB57V | Z0CI9Z | MCGRCH | ADVZSQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Multi Vonti | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Multi Vonti | Multi Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Reverse Convertible | Multi Vonti | Multi Vonti | ZKB Reverse Convertible on worst of Last Look | Worst of Callable Reverse Convertible | Multi Reverse Convertible |
|
Basiswert
|
Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Givaudan / Novartis AG / Sandoz Group AG | Alcon / Lonza Group N / Sandoz Group AG | Lonza Group N / Sandoz Group AG / Siegfried Hldg. AG | Lonza Group N / Sandoz Group AG / Straumann Hldg. AG | DKSH Hldg. AG / Sandoz Group AG / Siegfried Hldg. AG | Alcon / Sandoz Group AG / UBS Group AG | Galderma Group AG / Lonza Group N / Roche PS / Sandoz Group AG / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Sandoz Group AG | Givaudan / Novartis AG / Sandoz Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Partners Group Hldg. AG / Sandoz Group AG | ABB / Sandoz Group AG / Swisscom N | Givaudan / Novartis AG / Sandoz Group AG | Galderma Group AG / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Nestlé S.A. / Roche PS / Sandoz Group AG | Nestlé S.A. / Partners Group Hldg. AG / Sandoz Group AG / VAT Group | Compagnie Financière Richemont SA / Givaudan / Sandoz Group AG / Swiss Prime Site AG | Bachem Hldg. AG / Sandoz Group AG / Zurich Insurance Group AG | ABB / Helvetia Baloise Holding AG / Sandoz Group AG | Accelleron Industries AG / Julius Baer Group / Sandoz Group AG |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
09.11.2026 | 07.08.2029 | 25.08.2027 | 01.09.2028 | 24.09.2027 | 19.11.2026 | 24.11.2027 | 20.12.2027 | 23.07.2027 | 09.02.2029 | 14.02.2028 | 01.12.2026 | 18.03.2030 | 20.03.2028 | 27.09.2028 | 26.04.2027 | 26.04.2027 | 18.05.2027 | 08.06.2028 | 19.06.2028 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ausübungs-Preis
|
56.14 | 2'627.25 | 52.905 | 65.00 | 63.504 | 57.20 | 50.768 | 61.93 | 119.325 | 80.752 | 677.60 | 643.30 | 90.585 | 84.95 | 64.481 | 664.40 | 95.80 | 73.2825 | 62.355 | 52.115 |
|
Maximal- rendite p.a. |
79.17% | 5.38% | 13.13% | 8.71% | 7.21% | 2.97% | 12.08% | 6.42% | 6.87% | 5.20% | 18.55% | 28.74% | 6.00% | 6.91% | 6.76% | 26.00% | 4.56% | 18.29% | 8.23% | 9.74% |
| Geld | 93.40 | 97.64 | 93.62 | 91.80 | 98.89 | 99.30 | 96.75 | 97.50 | 99.84 | 98.60 | 86.90 | 97.20 | 99.08 | 99.30 | 100.27 | 90.50 | 100.30 | 100.35 | 98.75 | 98.47 |
| Brief | 94.40 | 98.44 | 94.42 | 92.60 | 99.69 | 100.10 | 97.55 | 98.30 | 100.64 | 99.40 | 87.70 | 98.00 | 100.08 | 100.10 | 101.08 | 91.30 | 101.10 | 101.10 | 99.55 | 99.27 |